Morgan Stanley’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Morgan Stanley’s Portfolio WGBS Stock Details WGBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1	Closed	–	–	6714
2016 Q4	$0	Hold	1	–	–	﹤0.01%	6636
2016 Q3	$0	Hold	1	–	–	﹤0.01%	6633
2016 Q2	$0	Sell	1 -5	-83%	-$19	﹤0.01%	6832
2016 Q1	$0	Hold	6	–	–	﹤0.01%	6876
2015 Q4	$0	Buy	6 +5	+500%	+$25	﹤0.01%	6943
2015 Q3	$0	Sell	1 -2	-67%	-$18	﹤0.01%	6863
2015 Q2	$0	Buy	3 +2	+200%	+$41	﹤0.01%	6872
2015 Q1	$0	Sell	1 -2	-67%	-$40	﹤0.01%	6771
2014 Q4	$0	Buy	3 +2	+200%	+$37	﹤0.01%	6786
2014 Q3	$0	Buy	+1	New	+$22	﹤0.01%	6763

Morgan Stanley's WGBS Position: Q1 2017 in Review

Morgan Stanley sold out of WaferGen Bio-systems, Inc. (WGBS) in Q1 2017, closing a stake of 1 share.

Morgan Stanley first reported a position in WGBS in Q3 2014 and held it in 10 quarters. The position peaked at $0 in Q4 2016. 0 funds tracked by Wall St. Rank hold WGBS as of Q1 2017.

Morgan Stanley reported no remaining WaferGen Bio-systems, Inc. position as of Q1 2017 after selling out during the quarter.
Morgan Stanley sold 1 WaferGen Bio-systems, Inc. share in Q1 2017.
Morgan Stanley first reported a position in WaferGen Bio-systems, Inc. in Q3 2014 and held it in 10 quarters.
Morgan Stanley's WaferGen Bio-systems, Inc. position peaked at $0 in Q4 2016.
0 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q1 2017.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.